Kenji Maeda

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

The Cloning of PIG-A, a Component in the Early Step of GPI-Anchor Biosynthesis

Toshio Miyata, Junji Takeda, Yoshiyasu Iida et al. · Science · 1993 · 536 citations

Life Sciences, Biochemistry, Molecular Biology +17

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Kyoji Horie, Toshio Miyata, Kenji Maeda et al. · Journal of Clinical Investigation · 1997 · 431 citations · Full text

Medicine, Biochemistry, Nephrology +17

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.

Toshio Miyata, Osamu Oda, Reiko Inagi et al. · Journal of Clinical Investigation · 1993 · 404 citations · Full text

Medicine, Biochemistry, Nephrology +17

Novel <i>bis</i> -Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro

Yasuhiro Koh, Hirotomo Nakata, Kenji Maeda et al. · Antimicrobial Agents and Chemotherapy · 2003 · 366 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17